SG153822A1 - Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias - Google Patents
Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmiasInfo
- Publication number
- SG153822A1 SG153822A1 SG200904004-9A SG2009040049A SG153822A1 SG 153822 A1 SG153822 A1 SG 153822A1 SG 2009040049 A SG2009040049 A SG 2009040049A SG 153822 A1 SG153822 A1 SG 153822A1
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- cardiac arrhythmias
- oxabispidine compounds
- novel
- novel oxabispidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401539A SE0401539D0 (sv) | 2004-06-15 | 2004-06-15 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG153822A1 true SG153822A1 (en) | 2009-07-29 |
Family
ID=32710059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200904004-9A SG153822A1 (en) | 2004-06-15 | 2005-06-13 | Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
Country Status (22)
Country | Link |
---|---|
US (2) | US7648985B2 (de) |
EP (1) | EP1765832B8 (de) |
JP (1) | JP2008502678A (de) |
KR (1) | KR20070039045A (de) |
CN (2) | CN101525339A (de) |
AR (1) | AR049823A1 (de) |
AU (2) | AU2005254924B2 (de) |
BR (1) | BRPI0512012A (de) |
CA (1) | CA2568895A1 (de) |
DK (1) | DK1765832T3 (de) |
ES (1) | ES2434043T3 (de) |
IL (1) | IL179560A0 (de) |
MX (1) | MXPA06014692A (de) |
NO (1) | NO20070148L (de) |
RU (1) | RU2379311C9 (de) |
SE (1) | SE0401539D0 (de) |
SG (1) | SG153822A1 (de) |
TW (1) | TW200612907A (de) |
UA (1) | UA85877C2 (de) |
UY (1) | UY28959A1 (de) |
WO (1) | WO2005123748A1 (de) |
ZA (2) | ZA200610418B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0401539D0 (sv) | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
WO2006135316A1 (en) * | 2005-06-13 | 2006-12-21 | Astrazeneca Ab | New oxabispidine compounds for the treatment of cardiac arrhythmias |
TW200734342A (en) * | 2005-12-15 | 2007-09-16 | Astrazeneca Ab | New compounds for the treatment of cardiac arrhythmias |
CN102066325A (zh) | 2008-06-16 | 2011-05-18 | 弗·哈夫曼-拉罗切有限公司 | 作为食欲肽受体拮抗剂的杂芳族单酰胺类 |
TW201004963A (en) * | 2008-07-03 | 2010-02-01 | Targacept Inc | Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
WO2010059119A1 (en) * | 2008-11-21 | 2010-05-27 | Astrazeneca Ab | A combination of tert -butyl (2-{7- [2- (4-cyano-2- f luorophenoxy) ethyl] -9-oxa-3, 7-diazabicyclo [3.3.1] non-3- yl } ethyl) carbamate and certain antiarrhythmic benzofurans |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
CN117384037B (zh) * | 2023-12-13 | 2024-03-08 | 山东国邦药业有限公司 | 一种二氟乙酸乙酯的制备方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3196154A (en) | 1962-05-17 | 1965-07-20 | Sterling Drug Inc | 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes |
US3503939A (en) | 1967-03-29 | 1970-03-31 | Du Pont | Polyamides from heterocyclic diamines |
CH488048A (de) | 1969-06-12 | 1970-03-31 | Inventa Ag | Verfahren zur Herstellung von Polyesterfasern mit verbesserter Gummihaftung |
DE2428792A1 (de) | 1974-06-14 | 1976-01-02 | Knoll Ag | Neue antiarrhythmika |
JPS5772977A (en) | 1980-10-23 | 1982-05-07 | Dainippon Ink & Chem Inc | Fluorine-containing diepoxy compound and its preparation |
DE3112055A1 (de) | 1981-03-27 | 1982-10-07 | Basf Ag, 6700 Ludwigshafen | Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel |
DE3234697A1 (de) | 1982-09-18 | 1984-03-22 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Neue diazabicyclo-(3,3,1)-nonane |
US4533713A (en) | 1983-05-06 | 1985-08-06 | Minnesota Mining And Manufacturing Company | Fluoroaliphaticsulfonamides containing oxirane groups and/or N-β-hydroxyalkylene groups |
PT88381B (pt) | 1987-09-09 | 1995-07-06 | Kali Chemie Pharma Gmbh | Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos |
DE3732094A1 (de) | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
US5140033A (en) | 1989-04-03 | 1992-08-18 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
US5110933A (en) | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
IL96507A0 (en) * | 1989-12-08 | 1991-08-16 | Merck & Co Inc | Nitrogen-containing spirocycles and pharmaceutical compositions containing them |
FI100151B (fi) | 1992-09-04 | 1997-09-30 | Nokia Mobile Phones Ltd | Tehonsäästö matkaviestimessä |
US5294621A (en) * | 1992-10-07 | 1994-03-15 | Ortho Pharmaceutical Corporation | Thieno tetrahydropyridines useful as class III antiarrhythmic agents |
JPH06284071A (ja) | 1993-01-27 | 1994-10-07 | Casio Comput Co Ltd | 無線受信機 |
US5468858A (en) | 1993-10-28 | 1995-11-21 | The Board Of Regents Of Oklahoma State University Physical Sciences | N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents |
FR2713081B1 (fr) | 1993-11-29 | 1996-01-12 | Celsa Lg | Filtre sanguin perfectionné à deux séries de pattes en pétales. |
US5831099A (en) | 1995-03-10 | 1998-11-03 | The United States Of America As Represented By The Secretary Of The Army | Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same |
SE9704709D0 (sv) | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
JP2002541249A (ja) | 1999-04-09 | 2002-12-03 | アストラゼネカ・アクチエボラーグ | アダマンタン誘導体 |
SE9903759D0 (sv) | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
AR030756A1 (es) | 2000-10-02 | 2003-09-03 | Astrazeneca Ab | Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas |
SE0101324D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | New process |
SE0101323D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | New process |
SE0101327D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | New crystalline forms |
SE0201662D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Pharmaceutical combination |
GB0223712D0 (en) | 2002-10-14 | 2002-11-20 | Astrazeneca Ab | Chemical intermediate |
SE0401540D0 (sv) | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
SE0401539D0 (sv) | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
-
2004
- 2004-06-15 SE SE0401539A patent/SE0401539D0/xx unknown
-
2005
- 2005-06-07 TW TW094118682A patent/TW200612907A/zh unknown
- 2005-06-13 BR BRPI0512012-8A patent/BRPI0512012A/pt not_active IP Right Cessation
- 2005-06-13 JP JP2007516430A patent/JP2008502678A/ja active Pending
- 2005-06-13 AU AU2005254924A patent/AU2005254924B2/en not_active Ceased
- 2005-06-13 KR KR1020077000930A patent/KR20070039045A/ko active IP Right Grant
- 2005-06-13 WO PCT/SE2005/000891 patent/WO2005123748A1/en active Application Filing
- 2005-06-13 MX MXPA06014692A patent/MXPA06014692A/es not_active Application Discontinuation
- 2005-06-13 CN CN200910134138A patent/CN101525339A/zh active Pending
- 2005-06-13 EP EP05752679.0A patent/EP1765832B8/de active Active
- 2005-06-13 US US11/570,451 patent/US7648985B2/en not_active Expired - Fee Related
- 2005-06-13 CA CA002568895A patent/CA2568895A1/en not_active Abandoned
- 2005-06-13 DK DK05752679.0T patent/DK1765832T3/da active
- 2005-06-13 ES ES05752679T patent/ES2434043T3/es active Active
- 2005-06-13 SG SG200904004-9A patent/SG153822A1/en unknown
- 2005-06-13 RU RU2006145202/04A patent/RU2379311C9/ru not_active IP Right Cessation
- 2005-06-13 CN CNA200580019259XA patent/CN1968956A/zh active Pending
- 2005-06-13 UA UAA200612695A patent/UA85877C2/uk unknown
- 2005-06-14 UY UY28959A patent/UY28959A1/es unknown
- 2005-06-14 AR ARP050102431A patent/AR049823A1/es not_active Application Discontinuation
-
2006
- 2006-11-23 IL IL179560A patent/IL179560A0/en unknown
- 2006-12-12 ZA ZA200610418A patent/ZA200610418B/en unknown
-
2007
- 2007-01-09 NO NO20070148A patent/NO20070148L/no not_active Application Discontinuation
- 2007-11-22 ZA ZA200710111A patent/ZA200710111B/xx unknown
-
2009
- 2009-07-06 US US12/497,792 patent/US20090270383A1/en not_active Abandoned
- 2009-10-02 AU AU2009222548A patent/AU2009222548A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101525339A (zh) | 2009-09-09 |
RU2379311C2 (ru) | 2010-01-20 |
CA2568895A1 (en) | 2005-12-29 |
ES2434043T3 (es) | 2013-12-13 |
DK1765832T3 (da) | 2013-10-21 |
NO20070148L (no) | 2007-01-09 |
RU2006145202A (ru) | 2008-07-20 |
TW200612907A (en) | 2006-05-01 |
EP1765832A1 (de) | 2007-03-28 |
ZA200610418B (en) | 2008-07-30 |
MXPA06014692A (es) | 2007-02-12 |
AU2005254924B2 (en) | 2009-08-27 |
AR049823A1 (es) | 2006-09-06 |
IL179560A0 (en) | 2007-05-15 |
US20090005558A1 (en) | 2009-01-01 |
US7648985B2 (en) | 2010-01-19 |
BRPI0512012A (pt) | 2008-02-06 |
AU2009222548A1 (en) | 2009-10-22 |
RU2379311C9 (ru) | 2010-05-27 |
ZA200710111B (en) | 2009-08-26 |
UA85877C2 (uk) | 2009-03-10 |
WO2005123748A1 (en) | 2005-12-29 |
US20090270383A1 (en) | 2009-10-29 |
CN1968956A (zh) | 2007-05-23 |
UY28959A1 (es) | 2006-01-31 |
KR20070039045A (ko) | 2007-04-11 |
JP2008502678A (ja) | 2008-01-31 |
SE0401539D0 (sv) | 2004-06-15 |
AU2005254924A1 (en) | 2005-12-29 |
EP1765832B1 (de) | 2013-08-14 |
EP1765832B8 (de) | 2013-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG153822A1 (en) | Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias | |
WO2004101528A3 (en) | Isoquinoline derivatives and their use as gfat inhibitors | |
MY148688A (en) | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors | |
EP1889842A4 (de) | Heterozyklische verbindung | |
WO2008123469A1 (ja) | 6員環アミド化合物およびその用途 | |
EE05556B1 (et) | 3-hüdroksü-3-metüülglutarüüli koensüümi kasutamine reduktaasi inhibiitorina ravimi valmistamiseks diabeetilise neuropaatia raviks | |
IL179634A0 (en) | 5-substituted-2-phenylamino-benzamides as mek inhibitor | |
IL181281A0 (en) | Extended release pellet formulation containing pramipexole of a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof | |
WO2006126082A3 (en) | Pyridine [3,4-b] pyrazinones as pde-5 inhibitors | |
WO2005103037A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
WO2004074218A3 (en) | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same | |
HK1104974A1 (en) | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof | |
WO2008005956A3 (en) | Pyrrolotriazine kinase inhibitors | |
EP1505068A4 (de) | PYRAZOLO (1,5-a) PYRIMIDINDERIVAT UND DIESES ENTHALTENDER NAD(P)H-OXIDASE-INHIBITOR | |
WO2006126081A3 (en) | Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors | |
IL186555A (en) | (4r, 9as) –5– Hydroxy – 4 – methyl – 6,10 – dioxo –10.9 a, 9,6,4,3 – hexahydro – 2 h – 1– oxa –8 a, 4a 4,2-diplooro-benzylamide carboxylic acid or its pharmacy salt, a preparation containing it and its use in the treatment or prevention of HIV | |
WO2006066879A3 (en) | Compounds with kv4 ion channel activity | |
NZ544009A (en) | Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain | |
NZ545506A (en) | Therapeutic agents useful for treating pain | |
GEP20104878B (en) | Inhibitors of microsomal triglyceride transfer protein and apo-b secretion | |
WO2006043149A3 (en) | Novel dicarboxylic acid derivatives | |
WO2007109251A3 (en) | Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases | |
EG25619A (en) | New process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds and application in the synthesis of iv abradine and addition saltsthereof wwith a pharmaceutically acceptable acid | |
WO2007017695A3 (en) | Dihydroxyanthraquinones and their use | |
EP2005954A4 (de) | Kit für die krebstherapie und pharmazeutische zusammensetzung zur krebstherapie |